Kura Oncology to Report First Quarter 2026 Financial Results
On May 5, 2026, Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focusing on precision medicines for cancer treatment, revealed that it is set to disclose its financial results for the first quarter of 2026 post the closure of U.S. financial markets on May 12, 2026. The management of Kura will conduct a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to delve into the financial outcomes and present a corporate update.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments